GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 80 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,298,948 | -29.9% | 666,127 | 0.0% | 0.10% | -31.4% |
| Q1 2023 | $1,851,833 | -19.4% | 666,127 | 0.0% | 0.15% | -21.9% |
| Q4 2022 | $2,298,138 | -61.6% | 666,127 | -71.4% | 0.20% | -58.6% |
| Q3 2022 | $5,989,000 | +6.2% | 2,330,504 | 0.0% | 0.47% | -3.7% |
| Q2 2022 | $5,640,000 | -41.3% | 2,330,504 | 0.0% | 0.49% | -33.7% |
| Q1 2022 | $9,602,000 | -68.3% | 2,330,504 | -1.1% | 0.74% | -61.7% |
| Q4 2021 | $30,302,000 | +19.1% | 2,356,282 | 0.0% | 1.94% | +26.1% |
| Q3 2021 | $25,448,000 | +18.3% | 2,356,282 | 0.0% | 1.54% | +29.5% |
| Q2 2021 | $21,513,000 | -0.7% | 2,356,282 | +2.5% | 1.19% | -4.0% |
| Q1 2021 | $21,674,000 | – | 2,298,382 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $17,536,000 | 1.82% |
| EcoR1 Capital, LLC | 3,421,287 | $13,480,000 | 0.72% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $8,123,000 | 0.63% |
| BVF INC/IL | 2,695,418 | $10,620,000 | 0.42% |
| Column Group LLC | 869,493 | $3,426,000 | 0.31% |
| Avidity Partners Management LP | 2,122,064 | $8,361,000 | 0.27% |
| Redmile Group, LLC | 3,059,794 | $12,056,000 | 0.15% |
| SkyOak Wealth, LLC | 69,778 | $275,000 | 0.09% |
| Tekla Capital Management LLC | 419,005 | $1,651,000 | 0.06% |
| Blackstone Inc. | 2,567,445 | $10,116,000 | 0.04% |